Capillary Technologies Board Approves USD 20M SessionM Acquisition Strategy

2 min read     Updated on 26 Feb 2026, 03:12 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Capillary Technologies India Limited received board approval for acquiring 100% shareholding in Session M Inc. from Mastercard for USD 20 million base consideration. The board meeting held on February 24, 2026, approved the transaction through wholly owned subsidiary Capillary Pte. Ltd., with completion expected within 180 days. SessionM, founded in 2011, recorded USD 50.50 million turnover in CY2025 and operates as a cloud-based loyalty platform serving North American, LATAM, and APAC markets.

33492041

*this image is generated using AI for illustrative purposes only.

Capillary Technologies India Limited has received board approval for its strategic acquisition of Session M Inc. from Mastercard, with the Board of Directors approving the USD 20.00 million base consideration deal during their meeting held on February 24, 2026. The company has filed comprehensive regulatory disclosures with BSE Limited and National Stock Exchange of India Limited under SEBI regulations.

Board Approval and Regulatory Compliance

The Board of Directors meeting, which commenced at 08:00 PM (IST) and concluded at 08:18 PM (IST) on February 24, 2026, approved the investment through the company's wholly owned subsidiary, Capillary Pte. Ltd. Company Secretary and Compliance Officer Gireddy Bhargavi Reddy digitally signed the regulatory filing on February 26, 2026, ensuring compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Details: Information
Meeting Date: February 24, 2026
Meeting Duration: 08:00 PM - 08:18 PM (IST)
Filing Date: February 26, 2026
Digital Signature Time: 10:29:54 +05'30'
Compliance Officer: Gireddy Bhargavi Reddy (A17091)

SessionM Acquisition Structure and Timeline

The acquisition involves 100% shareholding in Session M Inc., a wholly owned subsidiary of Mastercard Inc., along with its wholly owned subsidiary, Session M Czech Republic s.r.o. The transaction will be executed directly and through Capillary's step-down subsidiary, Capillary Technologies LLC, with completion expected within 180 days from the signing date.

Acquisition Details: Specifications
Target Entity: Session M Inc. (Mastercard subsidiary)
Shareholding Acquired: 100%
Base Consideration: USD 20.00 million
Completion Timeline: Within 180 days
Nature of Consideration: Cash consideration
Subsidiary Entity: Session M Czech Republic s.r.o.

SessionM Business Performance and Market Position

Session M Inc., founded in 2011 and acquired by Mastercard in 2019, operates as a leading cloud-based loyalty and engagement platform headquartered in the US. The company recorded a turnover of USD 50.50 million in CY2025, serving key industries including Food and Beverages, Consumer Goods/Retail, Airlines, and Oil and Gas across North America, LATAM, and APAC markets.

SessionM Financial Performance: Details
CY2025 Turnover: USD 50.50 million
CY2024 Turnover: USD 54.50 million
CY2023 Turnover: USD 57.00 million
Founded: 2011
Acquired by Mastercard: 2019
Primary Markets: North America, LATAM, APAC

Strategic Rationale and Market Expansion

The acquisition aligns with Capillary's inorganic growth strategy to strengthen its presence in North American and LATAM loyalty markets while adding to its APAC portfolio. The complementary business model, coupled with SessionM's long-tenured blue-chip clientele, is expected to enhance Capillary's ability to unlock post-acquisition efficiencies in the loyalty software-as-a-service (SaaS) space.

Strategic Benefits: Impact
Industry Focus: Loyalty Software as a Service (SaaS)
Geographic Expansion: North America and LATAM markets
Client Base: Long-tenured blue-chip clientele
Business Model: Complementary loyalty platform
Regulatory Approvals: Not Applicable
Related Party Transaction: No

Historical Stock Returns for Capillary Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-0.08%-1.27%-0.58%-15.06%-15.06%-15.06%
like16
dislike

Capillary Technologies Clarifies ESOP Exercise Price Mechanism Following Proxy Advisor Feedback

1 min read     Updated on 24 Feb 2026, 09:22 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Capillary Technologies India Limited issued a clarification on February 24, 2026, addressing proxy advisor concerns about exercise price determination under its ESOP 2021 scheme extension to subsidiary employees. The company clarified that exercise prices will be set by the Nomination and Remuneration Committee with a maximum 20% discount to the 90-day VWAP, ensuring objective and market-linked pricing. The clarification supports Special Resolution No. 1 in the company's postal ballot notice dated February 06, 2026, seeking shareholder approval for extending ESOP benefits to subsidiary employees in India and overseas.

33493960

*this image is generated using AI for illustrative purposes only.

Capillary Technologies India Limited has issued a regulatory clarification regarding the exercise price mechanism under its Employee Stock Option Plan (ESOP) 2021 scheme. The clarification, dated February 24, 2026, addresses feedback received from proxy advisors concerning the company's postal ballot notice issued on February 06, 2026.

Proxy Advisor Concerns Addressed

The company received feedback from proxy advisors highlighting concerns about the lack of clarity regarding the exercise price determination. The advisors noted that the exercise price could range between face value and market price, potentially allowing significant discounts to prevailing market prices.

Company's Pricing Mechanism Clarification

In response to these concerns, Capillary Technologies provided detailed clarification on its ESOP pricing structure:

Parameter Details
Exercise Price Determination Set by Nomination and Remuneration Committee (NRC)
Maximum Discount 20% to Volume Weighted Average Price (VWAP)
VWAP Calculation Period 90 trading days preceding the working day prior to grant date
Reference Exchange Stock exchange with highest trading volume for company shares
Minimum Exercise Price Face value of INR 2.00 per share

The company emphasized that this pricing mechanism is "objective, market-linked and transparent, and does not permit arbitrary pricing." The structure is designed to ensure continued alignment of employee incentives with long-term shareholder value creation.

Regulatory Compliance and Governance

Capillary Technologies confirmed that ESOP 2021 is implemented in strict accordance with:

  • Companies Act, 2013
  • SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
  • Supervision of the Nomination and Remuneration Committee

The company noted that extending ESOP benefits to subsidiary employees is a standard practice for listed groups, aimed at retention of critical talent and value creation at a consolidated level.

Postal Ballot Context

The clarification relates to Special Resolution No. 1 in the postal ballot notice, which seeks shareholder approval for ratification of extension of benefits under ESOP 2021 to employees of subsidiary companies, whether in India or overseas. The additional information has been made available on the company's website to provide shareholders with enhanced clarity before voting.

The clarification was signed by Gireddy Bhargavi Reddy, Company Secretary and Compliance Officer, and filed with both BSE Limited and National Stock Exchange of India Limited as required under Regulation 30 of SEBI listing regulations.

Historical Stock Returns for Capillary Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-0.08%-1.27%-0.58%-15.06%-15.06%-15.06%
like19
dislike

More News on Capillary Technologies

1 Year Returns:-15.06%